Atlas Trials

Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients

Clinical trial NCT00922688 · UNKNOWN

Trial details

NCT number
NCT00922688
Sponsor
Medical Center Alkmaar
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Colon Carcinoma
Start date
2010-12-01
Primary completion
2012-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.